Advisory Committee

Canada builds momentum and welcomes additional champions to the Global Carbon Pricing Challenge

Retrieved on: 
Wednesday, September 20, 2023

Together, they welcomed Norway and Denmark as new members of the Global Carbon Pricing Challenge, and the Côte d'Ivoire as a Friend of the Challenge.

Key Points: 
  • Together, they welcomed Norway and Denmark as new members of the Global Carbon Pricing Challenge, and the Côte d'Ivoire as a Friend of the Challenge.
  • The Global Carbon Pricing Challenge, launched by Prime Minister Trudeau at COP26, is a partnership of carbon pricing champions committed to accelerating climate action by setting an ambitious goal: tripling the coverage of carbon pricing mechanisms around the world to reach 60 percent of global emissions by 2030.
  • Together, the Challenge represents the expanding global partnership of champions working together to advance the global conversation on carbon pricing.
  • Partners of the Global Carbon Pricing Challenge are implementing, or scheduled to implement, carbon pricing and are committed to the goal of increasing coverage of carbon pricing to 60 percent of global emissions by 2030.

NOT ONE BUT THREE UNICORNS UP FOR BID DURING THE ART OF BOURBON AUCTION

Retrieved on: 
Tuesday, September 12, 2023

The online auction is free to bid but registration is required at artofbourbon.org .

Key Points: 
  • The online auction is free to bid but registration is required at artofbourbon.org .
  • Here are the auction highlights served up:
    The exceedingly rare George T. Stagg, sits at the crossroads of bourbon history.
  • In fact, his name is plastered on a few of them that have surfaced for auction.
  • Little did he know at the time, it would preserve the whiskey inside, protecting it from sunlight and outside vapors.

Alnylam Stock Trading Halted Today; FDA Advisory Committee to Review Supplemental New Drug Application for Patisiran for the Treatment of the Cardiomyopathy of ATTR Amyloidosis

Retrieved on: 
Wednesday, September 13, 2023

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that NASDAQ has halted trading of the Company’s common stock.

Key Points: 
  • Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that NASDAQ has halted trading of the Company’s common stock.
  • The U.S. Food and Drug Administration’s (FDA) Cardiovascular and Renal Drugs Advisory Committee is meeting today to review the supplemental New Drug Application for patisiran, an investigational RNAi therapeutic in development for the treatment of the cardiomyopathy of transthyretin-mediated (ATTR) amyloidosis.
  • As previously announced, the FDA has set an action date of October 8, 2023 under the Prescription Drug User Fee Act.
  • Patisiran is the established name for ONPATTRO®, which is currently approved by the FDA for the treatment of the polyneuropathy of hereditary ATTR amyloidosis in adults.

AARON'S NAMES TWO NEW INDEPENDENT BOARD MEMBERS

Retrieved on: 
Wednesday, September 13, 2023

"On behalf of the entire Board of Directors, I would like to welcome Wali and Kris as the newest members of the Aaron's board," said John Robinson, chair of The Aaron's Company Board of Directors.

Key Points: 
  • "On behalf of the entire Board of Directors, I would like to welcome Wali and Kris as the newest members of the Aaron's board," said John Robinson, chair of The Aaron's Company Board of Directors.
  • He also currently serves as a Venture Partner for Delta-v Capital, a technology-focused growth capital investment firm.
  • In addition, he is the principal investor and co-founder of Millie's Homemade Ice Cream and Southern Steer Franchising.
  • He is currently a Trustee of Washington and Lee University and also serves as a board member of several non-profit and charitable organizations.

DISABILITY COMMUNITY INVOLVEMENT KEY TO SOLVING HEALTH DISPARITIES

Retrieved on: 
Tuesday, September 12, 2023

HARRISBURG, Pa., Sept. 12, 2023 /PRNewswire/ -- The COVID-19 pandemic was devastating for people with disabilities, their families, caregivers, and the entire disability community. Solving the health disparities faced by people with disabilities starts with their involvement in policy making and healthcare decisions, according to a new report from the COVID-19 Health Disparities Task Force facilitated by The Arc of Pennsylvania.

Key Points: 
  • Solving the health disparities faced by people with disabilities starts with their involvement in policy making and healthcare decisions, according to a new report from the COVID-19 Health Disparities Task Force facilitated by The Arc of Pennsylvania.
  • The report notes that the health decisions for people with disabilities are made without their insight and involvement, despite the community being among the country's largest groups experiencing health disparities.
  • Without their insights, health disparities will continue to plague the disability community."
  • The Task Force's latest report, " Recommendations for Addressing COVID-19 Health Disparities Among the Disability Community ," concludes a multi-year effort funded with a grant from the Pennsylvania Department of Health through the CDC's National Initiative to Address COVID-19 Health Disparities Among Populations at High-Risk and Underserved.

FDA Takes Action on Updated mRNA COVID-19 Vaccines to Better Protect Against Currently Circulating Variants

Retrieved on: 
Monday, September 11, 2023

Individuals who receive an updated mRNA COVID-19 vaccine may experience similar side effects as those reported by individuals who previously received mRNA COVID-19 vaccines as described in the respective prescribing information or fact sheets.

Key Points: 
  • Individuals who receive an updated mRNA COVID-19 vaccine may experience similar side effects as those reported by individuals who previously received mRNA COVID-19 vaccines as described in the respective prescribing information or fact sheets.
  • The updated vaccines are expected to provide good protection against COVID-19 from the currently circulating variants.
  • Manufacturers have publicly announced that the updated vaccines would be ready this fall, and the FDA anticipates that the updated vaccines will be available in the near future.
  • This suggests that the vaccines are a good match for protecting against the currently circulating COVID-19 variants.

Presidio Investors Welcomes Javier Saade as New Operating Partner

Retrieved on: 
Wednesday, September 6, 2023

Presidio Investors, a leading middle market private equity firm that capitalizes technology, media, and financial services businesses, is pleased to announce that Javier Saade has joined the firm as Operating Partner.

Key Points: 
  • Presidio Investors, a leading middle market private equity firm that capitalizes technology, media, and financial services businesses, is pleased to announce that Javier Saade has joined the firm as Operating Partner.
  • He is a principled leader that has over three decades of broad experience as an investor, board member, founder, operating executive, and former policymaker.
  • View the full release here: https://www.businesswire.com/news/home/20230906464989/en/
    Karl Schade, Managing Partner, said, "We are thrilled to welcome Javier to our team as our newest operating partner.
  • He is also Managing Partner of Impact Master Holdings, Venture Partner at Fenway Summer, Contributor at CNBC, and Executive Fellow at Harvard Business School.

Canada West Land Services welcomes Janice Redmond as Senior Manager, Corporate Development

Retrieved on: 
Tuesday, September 5, 2023

CALGARY, Alberta, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Canada West Land Services (“CWL”) is pleased to announce the appointment of Janice Redmond as Senior Manager, Corporate Development.

Key Points: 
  • CALGARY, Alberta, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Canada West Land Services (“CWL”) is pleased to announce the appointment of Janice Redmond as Senior Manager, Corporate Development.
  • Her extensive experience and industry expertise will be pivotal as we embark on the next phase of growth and expansion.
  • Working with the team as the Senior Manager, Corporate Development is an incredible opportunity I look forward to.
  • Prior to joining CWL, Janice spearheaded the development and execution of strategic initiatives, overseeing vital areas such as business development, marketing, corporate growth, and event management.

Leonard A. Lauder Decides Not to Stand for Re-Election to The Estée Lauder Companies Board of Directors

Retrieved on: 
Thursday, August 24, 2023

Pursuant to the stockholders’ agreement among Lauder family members and the Company, Leonard Lauder has the right to designate two directors of the Company.

Key Points: 
  • Pursuant to the stockholders’ agreement among Lauder family members and the Company, Leonard Lauder has the right to designate two directors of the Company.
  • In addition to his son William P. Lauder, who serves as Executive Chairman, Leonard Lauder has designated his son Gary M. Lauder to serve on the Board.
  • Leonard Lauder formally joined The Estée Lauder Companies in 1958 and served as President from 1972 to 1995 and as Chief Executive Officer from 1982 to 1999.
  • In addition to his activities with The Estée Lauder Companies, Leonard Lauder is extremely involved in the worlds of education, art, politics, and philanthropy.

GSK Announces AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Is Now Available at All Major US Retail Pharmacies

Retrieved on: 
Thursday, August 17, 2023

GSK plc (LSE/NYSE: GSK) today announced that AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) is now available in the US at all major retail pharmacies.

Key Points: 
  • GSK plc (LSE/NYSE: GSK) today announced that AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) is now available in the US at all major retail pharmacies.
  • Shared clinical decision making empowers patients, in consultation with their healthcare providers, to decide whether RSV vaccination is appropriate for them.
  • AREXVY is indicated for the prevention of RSV-lower respiratory tract disease (LRTD) in individuals aged 60 years and older.
  • Rob Truckenmiller, Senior Vice President, Head of US Vaccines, GSK, said: “We are excited to announce that AREXVY is now available to older adults in major retail pharmacies across the US ahead of this year’s RSV season.